Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Glabellar Lines in Chinese Patients
NCT00408785Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Primary completion
- May 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in glabellar lines comparing Botox 20U with Placebo (2 arms). Primary endpoint: Investigator's rating of Glabellar line severity at maximum frown at Day 30. Started Nov 2006; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT00408785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408785.